MC2081A1 - Procede de preparation cyclohexaneacetamides - Google Patents

Procede de preparation cyclohexaneacetamides

Info

Publication number
MC2081A1
MC2081A1 MC902092A MC2092A MC2081A1 MC 2081 A1 MC2081 A1 MC 2081A1 MC 902092 A MC902092 A MC 902092A MC 2092 A MC2092 A MC 2092A MC 2081 A1 MC2081 A1 MC 2081A1
Authority
MC
Monaco
Prior art keywords
methyl
oxo
phenylmethyl
alkyl group
formula
Prior art date
Application number
MC902092A
Other languages
English (en)
French (fr)
Inventor
Lee Olson Gary
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2081A1 publication Critical patent/MC2081A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Packging For Living Organisms, Food Or Medicinal Products That Are Sensitive To Environmental Conditiond (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
MC902092A 1989-01-17 1990-01-16 Procede de preparation cyclohexaneacetamides MC2081A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29772689A 1989-01-17 1989-01-17
US37764389A 1989-07-10 1989-07-10

Publications (1)

Publication Number Publication Date
MC2081A1 true MC2081A1 (fr) 1991-01-07

Family

ID=26970288

Family Applications (1)

Application Number Title Priority Date Filing Date
MC902092A MC2081A1 (fr) 1989-01-17 1990-01-16 Procede de preparation cyclohexaneacetamides

Country Status (16)

Country Link
EP (1) EP0381959B1 (de)
JP (1) JPH02229154A (de)
KR (1) KR900011759A (de)
AT (1) ATE122037T1 (de)
AU (1) AU625157B2 (de)
CA (1) CA2007732A1 (de)
DE (1) DE69019007T2 (de)
DK (1) DK0381959T3 (de)
ES (1) ES2071685T3 (de)
FI (1) FI900231A7 (de)
HU (1) HUT53607A (de)
IL (1) IL93051A0 (de)
MC (1) MC2081A1 (de)
NO (1) NO174386C (de)
NZ (1) NZ232112A (de)
PT (1) PT92874A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4404848A1 (de) * 1994-02-16 1995-08-17 Hoechst Ag Substituierte Cyclohexanolester, ihre Verwendung zur Behandlung von Krankheiten und pharmazeutische Präparate
KR100395779B1 (ko) * 2001-05-25 2003-08-21 한국화학연구원 임의적으로 베타-위치가 치환된 알파-아릴알킬기의 제거를통해 3급 아미드 화합물로부터 2급 아미드 화합물을제조하는 방법
EP3260118B1 (de) 2008-10-16 2021-03-24 The Johns Hopkins University Verfahren und zusammensetzungen zur verbesserung der kognitiven funktion
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2968220B1 (de) 2013-03-15 2021-05-05 Agenebio, Inc. Verfahren und zusammensetzungen zur verbesserung von kognitiven funktionen
NZ738682A (en) 2015-05-22 2022-01-28 Agenebio Inc Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
IT1224168B (it) * 1986-08-01 1990-09-26 Finanziaria R F Spa Ora Finanz Derivati del pirrolidin-2-one ad attivita' nootropa

Also Published As

Publication number Publication date
JPH02229154A (ja) 1990-09-11
NO174386C (no) 1994-04-27
AU625157B2 (en) 1992-07-02
NO900234D0 (no) 1990-01-16
NO900234L (no) 1990-07-18
EP0381959B1 (de) 1995-05-03
DE69019007D1 (de) 1995-06-08
EP0381959A1 (de) 1990-08-16
FI900231A7 (fi) 1990-07-18
PT92874A (pt) 1990-07-31
CA2007732A1 (en) 1990-07-17
ES2071685T3 (es) 1995-07-01
NO174386B (no) 1994-01-17
AU4798890A (en) 1990-07-26
ATE122037T1 (de) 1995-05-15
HUT53607A (en) 1990-11-28
DE69019007T2 (de) 1995-09-14
HU900127D0 (en) 1990-03-28
NZ232112A (en) 1992-07-28
IL93051A0 (en) 1990-11-05
KR900011759A (ko) 1990-08-02
FI900231A0 (fi) 1990-01-16
DK0381959T3 (da) 1995-09-04

Similar Documents

Publication Publication Date Title
CA2339273C (en) Branched alkyl pyrrolidine-3-carboxylic acids
CH651548A5 (fr) Derives mercapto-acyles de diverses prolines 4-substituees a action anti-hypertensive.
US6566553B2 (en) Synthesis of clasto-lactacystin β-lactone and analogs thereof
CH664152A5 (fr) Derives de tetrahydrocarbazolones.
JP2013035842A (ja) 新規１−アリール−３−アザビシクロ［３．１．０］ヘキサン：調製および神経精神障害の処理への使用
EP1682503A2 (de) Derivate von n-[phenyl(alkylpiperidin-2-yl)methyl]benzamid, verfahren zu deren herstellung und deren anwendung in therapeutika
CA2625642C (en) Prolinamide derivatives as sodium channel modulators
FR2697252A1 (fr) Dérivés de 1,2,3,5,6,7,8,8a-octahydro-5,5,8a-triméthyl-(8abeta)-6-isoquinolineamine, leur procédé de préparation et leur utilisation en thérapeutique.
FR2606018A1 (fr) Nouveaux a-aminoacides substitues, leur preparation et leur utilisation en therapeutique comme medicaments
EP0618193B1 (de) Bicyclische Stichstoff enthaltende Derivate als Prolyl-Endopeptidase Inhibitoren
US5053422A (en) Psychotropic perhydroazacycloalka [1,2-A] imidazole derivatives
Alcaraz et al. Asymmetric syntheses of 1-amino-2-phenyl (alkyl) cyclopropanecarboxylic acids by diastereoselective cyclopropanation of highly functionalized monochiral olefines
EP0381959B1 (de) Cyclohexanacetamid-Derivate
DE69217613T2 (de) Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
Knight et al. β-Hydroxypiperidinecarboxylates: additions to the chiral pool from bakers’ yeast reductions of β-ketopiperidinecarboxylates
BE1000039A4 (fr) Nouvelles 8 alpha-acylamino-ergolines, leur preparation et leur utilisation comme medicaments.
US5015653A (en) [(5-oxo)-2-pyrrolidinyl)methyl]cyclohexaneacetamides, compositions and use
HU180596B (en) Process for producing pyrrolydine derivatives
JPH0128019B2 (de)
JPH02262557A (ja) 縮合ベンゼン誘導体、それを含有する医薬及び該化合物の製造中間体
DE69121920T2 (de) Antagonisten reizübertragender aminosäuren
Bonnaud et al. Stereoselective synthesis of cis and trans 2‐substituted 1‐phenyl‐3‐azabicyclo [3.1. 0] hexanes
EP0820455A1 (de) 5H, 10H-IMIDAZO [1,2-a] INDENO [1,2-e] PYRAZIN -4-ONE DERIVATE IHRE HERSTELLUNG UND DIESE ENTHALTENDE ARZNEIMITTEL
FR2503164A1 (fr) Procede de preparation d'alcoloides de l'ergot de seigle
Kise et al. Diastereoselective intermolecular coupling of chiral α-imino amides with ketones by electroreduction

Legal Events

Date Code Title Description
YP Annual fee paid